1345983-68-7

Upstream product

• 1345983-67-6 [4-bromo-2,5-bis(methyloxy)phenyl](phenyl)methanone 
• 25245-34-5 1-bromo-2,5-dimethoxybenzene 
• 98-88-4 benzoyl chloride 

Downstream Products

• 1345983-66-5 S-[5-bromo-4-(methyloxy)-2-(phenylcarbonyl)phenyl]diethylthiocarbamate 
• 1345983-70-1 [2-[(2-amino-2-butylhexanyl)thio]-4-bromo-5-(methyloxy)phenyl](phenyl)methanone 
• 1345983-71-2 8-bromo-3,3-dibutyl-7-(methyloxy)-5-phenyl-2,3-dihydro-1,4-benzothiazepine 
• 1345983-72-3 methyl 3,3-dibutyl-7-(methyloxy)-5-phenyl-2,3-dihydro-1,4-benzothiazepine-8-carboxylate 
• 1345983-73-4 [3,3-dibutyl-7-(methyloxy)-5-phenyl-2,3-dihydro-1,4-benzothiazepin-8-yl]methanol 
• 1345983-74-5 [3,3-dibutyl-7-(methyloxy)-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methanol 
• 1345983-75-6 [3,3-dibutyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methanol 
• 1345983-76-7 3,3-dibutyl-7-(methyloxy)-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepine-8-carbaldehyde 1,1-dioxide 
• 1345983-77-8 diethyl {[3,3-dibutyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}phosphonate 
• 1345983-78-9 8-(bromomethyl)-3,3-dibutyl-7-(methyloxy)-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepine 1,1-dioxide 
• 1345983-26-7 3-({[3,3-dibutyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amino)pentanedioic acid trifluoroacetate 
• 1345984-20-4 dimethyl 3-({[3,3-dibutyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amino)pentanedioate 
• 1345983-28-9 N-{[3,3-dibutyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}glycine trifluoroacetate 
• 1345984-21-5 1,1-dimethylethyl N-{[3,3-dibutyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}glycinate 

Relevant academic research and scientific papers

ALPHA-CARBOLINES FOR THE TREATMENT OF CANCER

The present invention relates to inhibitors of the oncogenic protein kinase ALK of formula (I) as herein described and pharmaceutical compositions thereof, as well as to key intermediates towards their synthesis. The compounds of formula (I) are useful in

CHEMICAL COMPOUNDS

Compounds of Formula (I) and methods for treating metabolic disorders are disclosed.